The Taskforce brings together the peak health professional bodies across Australia whose members are providing clinical care to people with COVID-19.
We are undertaking continuous evidence surveillance to identify and rapidly synthesise emerging research in order to provide national, evidence-based guidelines for the clinical care of people with COVID-19. The guidelines address questions that are specific to managing COVID-19 and cover the full disease course across mild, moderate, severe and critical illness.
These are ‘living’ guidelines, updated with new research in near real-time in order to give reliable, up-to-the minute advice to clinicians providing frontline care in this unprecedented global health crisis.
Australia is a world-leader in the development of living guidelines through the work of the Australian Living Evidence Consortium and in partnership with Cochrane, the world’s most trusted provider of health evidence. This considerable expertise has now been deployed to ensure every Australian clinician has access to a single source of trustworthy advice about critical aspects of COVID-19 care.
Our goal is to provide a growing set of evidence-based recommendations to guide care for people with COVID-19, which are kept up-to-date as new research becomes available.
Each week we identify, evaluate and synthesise evidence to be used as the basis of new recommendations. We also identify and include any new research evidence that might influence our existing recommendations. Our panels of clinical experts meet weekly to review the evidence and make new and updated recommendations, which are endorsed by our Taskforce members and immediately published online.
We are moving quickly, and value your input and suggestions as we continue to revise, expand and improve our guidelines.
*The Australian Living Evidence Consortium members are:
The Consumer Panel is co-convened with our community partner, the Consumer’s Health Forum of Australia